NORTHERN TRUST CORP - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 76 filers reported holding HUMACYTE INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$1,519,457
+6.3%
518,586
+3.7%
0.00%
Q2 2023$1,430,023
-4.7%
500,008
+2.9%
0.00%
Q1 2023$1,501,236
+39.5%
485,837
-4.7%
0.00%
Q4 2022$1,075,894
+39.9%
509,902
+116.4%
0.00%
Q3 2022$769,000
-1.0%
235,642
-2.8%
0.00%
Q2 2022$777,000
-9.9%
242,389
+98.5%
0.00%
Q1 2022$862,000
-4.3%
122,089
-1.8%
0.00%
Q4 2021$901,000124,3760.00%
Other shareholders
HUMACYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders